Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

The Latest: EU official: US isn't being loyal or transparent

09/20/2021 | 04:44pm EDT

The Latest on the U.N. General Assembly (all times local):

UNITED NATIONS -- The top European Union official is criticizing the United States for a “lack of transparency and loyalty” towards its trans-Atlantic partners, as evidenced by America’s unilateral decision to withdraw from Afghanistan and its new Pacific defense pact that left France out in the cold.

EU Council President Charles Michel told a small group of reporters Monday that these U.S. decisions showed “a clear lack of transparency and loyalty, loyalty and loyalty,” despite President Joe Biden’s announcement earlier this year that “America is back” after four years of former president Donald Trump’s “America First” policies.

Michel repeated that “the trans-Atlantic alliance is a paramount alliance for us in the EU.”

“I’m not putting in question this alliance," he added, “but I’m asking: Is there a doubt in the United States about the importance of this alliance with Europe?”

He said the announcement of the new U.S.-UK-Australia alliance and Washington’s decision, with the UK, to sell nuclear-powered submarines to Australia in a move that killed a pre-existing deal between France and Australia, has “consequences.”

Michel said “there is the need for a debate on what does it mean for us in Europe.” He said a discussion on the EU’s future relationship with China was already on the agenda of an upcoming informal dinner.

NEW YORK — British Prime Minister Boris Johnson stressed the importance of coronavirus vaccines during a meeting with Brazilian President Jair Bolsonaro, who says he has not been inoculated.

The two men met Monday on the sidelines of the United Nations General Assembly in New York. As journalists were ushered out of the room at the start of the bilateral meeting, Johnson said: “Thanks everybody, get AstraZeneca vaccines.”

Johnson told Bolsonaro: “I’ve had it twice,” referring to the AstraZeneca vaccine, which was developed at Oxford University.

The Brazilian leader pointed at himself and said “not yet,” then laughed.

In a statement after the meeting, Johnson’s office said the prime minister had “underlined the importance of vaccines as our best tool to fight the virus and save lives around the world, and emphasised the important role the Oxford-AstraZeneca vaccine has played in the U.K, Brazil and elsewhere.”

NEW YORK — Leaders, government ministers and other dignitaries from more than 120 countries and international organizations headed to ground zero Monday for a U.N. commemoration of the 20th anniversary of the 9/11 terror attacks.

The U.N. said more than 300 people went to the National Sept. 11Memorial & Museum for the ceremony. Memorial President Alice Greenwald called it “a powerful demonstration of global solidarity” with terror victims.

The visitors included Austrian President Alexander Van der Bellen; Cyprus’ President Nicos Anastasiades; Guyanese President Irfaan Ali; Lithuanian President Gitanas Nauseda; Sri Lankan President Gotabaya Rajapaksa and Zeljko Komsic, the Croat representative in Bosnia’s multiethnic presidency.

They are in New York for this week’s big meeting at the U.N. General Assembly, about four miles (6.5 km) from the site where two hijacked planes plowed into the World Trade Center’s twin towers on Sept. 11, 2001. Ultimately, nearly 3,000 people from more than 90 countries were killed at the trade center, the Pentagon and a Pennsylvania field.

Spanish Foreign Minister José Manuel Albares urged those gathered at Monday’s tribute to “restate our commitment towards our common collaboration to fight against terrorism and in favor of the victims” as he and the U.N.’s top counterterrorism official, Vladimir Voronkov, laid wreaths.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about ASTRAZENECA PLC
06:48aASTRAZENECA : Deutsche Bank reiterates its Buy rating
MD
02:58aVACCINATED BUT STUCK : Indians await WHO nod for homegrown shot to travel abroad
RE
10/25AstraZeneca PLC Announces Positive High-Level Results from the TOPAZ-1 Phase III Trial
CI
10/25ASTRAZENECA : Daiichi Sankyo in Clinical Trial Collaboration to Evaluate Datopotamab Derux..
MT
10/25WALL STREET STOCK EXCHANGE : 84% of Q3 earnings reports exceed expectations
10/25ANALYST RECOMMENDATIONS : American Express, Beyond Meat, Microsoft, Oracle, Weibo...
10/25UNIVERSITY OF BIRMINGHAM : A third of leukaemia patients do not generate any antibody resp..
AQ
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
AQ
10/25ASTRAZENECA : JP Morgan reiterates its Buy rating
MD
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
PU
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 441 M - -
Net income 2021 4 862 M - -
Net Debt 2021 24 715 M - -
P/E ratio 2021 35,9x
Yield 2021 2,27%
Capitalization 192 B 192 B -
EV / Sales 2021 6,11x
EV / Sales 2022 4,95x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 123,93 $
Average target price 137,83 $
Spread / Average Target 11,2%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC22.92%190 828
JOHNSON & JOHNSON5.32%431 938
ROCHE HOLDING AG15.61%338 364
NOVO NORDISK A/S59.69%243 351
PFIZER, INC.17.22%241 929
ELI LILLY AND COMPANY47.15%222 158